The largest database of trusted experimental protocols

12 protocols using protein a g agarose beads

1

Cell Lysis and E2F1/HDAC1 Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were grown to about 70% confluency, then washed twice with 1xPBS, and collected in CHAPS buffer (25 mM HEPES, 2 mM EGTA, 2.5 mM MgCl2 and 0.3% CHAPS). After 20 min of incubation on ice and 10 min of centrifugation at 4°C, 500 μg of Lysates were pre-cleared with 30 μl Protein A/G Agarose beads (Invitrogen) for 2h and supernatants were collected. IPs were performed by mixing supernatants with 3 μg of E2F1 (Santa Cruz) or HDAC1 (Santa Cruz) antibodies or IgG (Abcam), together with 30 μl of Protein A/G Agarose beads, for overnight at 4°C. After 3 washes of PBS buffer, the immuno-complexes were eluted by 10 min boiling in 2x SDS loading buffer.
+ Open protocol
+ Expand
2

Investigating NLRP3 Ubiquitination Interactome

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfect Myc-NLRP3, HA-Ub, GFP-YAP, Flag-AMPK plasmids (all purchased from Shanghai Bioengineering) and proteasome inhibitor MG132 (0.5, 1.0, 2.0 μmol/L) (Y-13259, MCE, Shanghai, China) of different concentrations into HEK293T cells, add Protein A/G agarose beads (ab193262, Abcam) to remove non-specific proteins, then immunoprecipitate using anti-Myc antibody (#2272, 1/1000; CST, human and mouse). Next, wash the co-immunoprecipitated samples multiple times to remove non-specific proteins and impurities, retaining the ubiquitinated protein and its interacting protein complex. Then, use anti-Myc antibody (#2272, 1/1000; CST, human and mouse), anti-Flag antibody (MA1-91878, 1/1000; Sigma, USA), anti-HA antibody (#2367, 1/1000; CST, human and mouse), and anti-GFP antibody (#2956, 1/1000; CST, human and mouse) for immunoblotting detection [24 (link)].
+ Open protocol
+ Expand
3

Immunoprecipitation of Transcription Factor

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-Tf antibody was immobilized on Protein A/G agarose beads (Abcam) according to manufacturer’s protocol. Beads were incubated with brain extracts for 4 h at 4 °C, following which the supernatant was removed and the beads washed three times with PBS. Antigen-antibody complex was treated by heating the beads at 95 °C in SDS-PAGE sample buffer, which was used as a bound fraction. The supernatant was used as an unbound fraction.
+ Open protocol
+ Expand
4

Immunoprecipitation of PARK2 and BECN1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibroblasts were washed twice, harvested in PBS, and then lyzed in ice-cold IP lysis buffer containing 50 mM Tris, 1 mM EDTA, 0.5% NP-40, 150 mM NaCl, 10% glycerol and 1 mM PMSF for 30 min. Total cell extracts were centrifuged for 30 min at 12,000 rpm at 4 °C, then the protein A/G agarose beads (Beyotime Bio, Shanghai, China) or control IgG (Santa Cruz) was incubated with the supernatant for 1 h as a pretreatment. Lysates were incubated overnight with anti-PARK2 monoclonal antibody (Abcam, No. ab179812), anti-BECN1 monoclonal antibody (Abcam, No. ab207612) or control IgG and protein A/G agarose beads on rotary shaker at 4 °C. The immunoprecipitated complexes were collected by centrifugation at 3000 rpm for 5 min at 4 °C, and the beads were washed three times with IP lysis buffer and resuspended in 2 × SDS loading buffer. Subsequently, the immunoprecipitates complexes were eluted from the beads at 99 °C for 5 min. The eluted proteins were determined by Western blot analysis with indicated antibodies.
+ Open protocol
+ Expand
5

Immunoprecipitation of YB1 in H2O2-treated H9c2 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9c2 cells were treated with 50 mM H2O2. After 6 h, the cells were lysed with NP40 lysis buffer (Beyotime Institute of Biotechnology). Following centrifugation at 12,000 × g for 10 min at 4°C, the cell lysates were precleared with protein A/G agarose beads (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and an unrelated antibody from the same species of origin. Subsequently, the samples were incubated with the anti-YB1 antibody (1:30; cat. no. ab76149; Abcam) and protein A/G agarose beads overnight at 4°C with continuous rotation. The beads were washed five times in lysis buffer, and the immunoprecipitates were eluted from protein A/G agarose beads by heating at 100°C for 5 min. Following centrifugation at 12,000 × g for 10 min at 4°C, the samples were analyzed by western blotting.
+ Open protocol
+ Expand
6

Detecting G6PD O-GlcNAcylation by IP-Western

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were collected and lysed using RIPA lysis buffer (Beyotime Biotechnology) containing protease inhibitors for 30 min at 4°C. The protein was incubated with anti-G6PD and anti-IgG antibodies at 4°C overnight. Then Protein A/G agarose beads (Abcam) was added to each tube. After incubation again at 4°C for 3 h, the beads were collected by centrifugation at 2,000 x g for 2 min. Subsequently, the beads were washed with IP wash buffer three times, followed by adding 40 μL 2× loading buffer and denaturing at 100°C for 5 min. Western blot was then performed. The anti-O-GlcNAC antibody (RL2, Thermo Scientific) was used to test the O-GlcNAcylation of G6PD.
+ Open protocol
+ Expand
7

Co-immunoprecipitation Protocol for Protein Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Co-immunoprecipitation (co-IP) was performed as previously described (Yan et al., 2017 (link)). The cells were washed once with cold PBS, lysed in lysis buffer for IP (Beyotime, #P0013) containing a protease inhibitor cocktail (Roche) at 4°C for 1 h, and then centrifuged at 12,000 g for 15 min at 4°C. After centrifugation, a small fraction of the supernatant was frozen for subsequent analysis (cell extract) as the input. The remaining fraction was incubated at 4°C with 1 μg of the desired antibody on a rotator overnight. Then, the mixtures were incubated with Protein A/G agarose beads (Abcam, #ab193262) with rotation at 4°C for 6 h. After the incubation, the beads were washed three times with wash buffer, boiled in loading buffer at 95°C, and then subjected to western blotting. The following specific secondary antibodies were used to avoid overlap of the bands for the target proteins with those of the immunoglobulin light chain and heavy chain: IPKine HRP Goat AntiMouse IgG HCS (Abbkine, #A25112, 1:5,000), IPKine HRP Goat AntiRabbit IgG HCS (Abbkine, #A25222, 1:5,000), IPKine HRP AffiniPure Goat AntiMouse IgG Light Chain (Abbkine, #A25012, 1:5,000), and IPKine HRP AffiniPure Mouse AntiRabbit IgG Light Chain (Abbkine, #A25022, 1:5,000).
+ Open protocol
+ Expand
8

Immunoprecipitation of Alpha-Synuclein from CSF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein A/G agarose beads (Abcam) were pretreated with 1% BSA, dissolved in phosphate-buffered saline (PBS) buffer (20 mM phosphate, 150 mM NaCl, pH-7.4), to block any unspecific interactions. A large volume of CSF (50 mL) was pulled down from healthy controls, and endogenous immunoglobulins were depleted from the sample during 2-h incubation with Protein A/G agarose beads, followed by elimination of beads via centrifugation. The antibody recognizing αSN, used for similar approaches previously (25 (link)–27 (link, link)), was added to the obtained solution and incubated overnight in 4 °C. Thereafter, the sample was incubated for 6 h with Protein A/G agarose beads at room temperature (RT) and spun. The beads were washed, and protein elution was conducted by 0.2 M glycine pH 2.6. The sample was dialyzed, lyophilized, and stored at −20 °C for further analysis. In parallel, separate positive and negative control samples were prepared. Recombinant αSN served as a positive control. The negative control was a CSF sample without addition of the primary anti-αSN antibody.
+ Open protocol
+ Expand
9

CD44 Protein Immunoprecipitation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoprecipitation was conducted with protein A/G agarose beads (Thermo Fisher Scientific) according to the manufacturer’s instructions. Cells after transfection were lysed and incubated in immunoprecipitation lysis buffer (Beyotime) for 10 min at room temperature. The extracts were incubated with anti-CD44-antibody (2 μg/ml, Abcam) at 4 °C overnight, and the immunoprecipitates were purified by protein A/G agarose beads with gentle rocking. The beads were washed for three times with extraction buffer and resuspended in 20 μl SDS loading buffer. The whole cell lysates and immunoprecipitates were incubated at 70 °C for 10 min followed with western blot analysis.
+ Open protocol
+ Expand
10

Confirming MBL Inhibition of LOX1-ox-LDL Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Co-IP analysis was used to confirm MBL can inhibiting LOX1-ox-LDL binding. The treated cells were collected, and proteins were extracted. An ultraviolet spectrophotometer was used to determine the protein concentration. Then, 20 μL of Protein A/G agarose beads, 180 μL of PBS, and MBL antibody at a ratio of 1:100 (Abcam, Cambridge, UK) was mixed and incubated at room temperature for 1.5 h with rotation. Samples were centrifuged at 4 °C for 2 min at 2000 rpm/min and washed with PBS 3 times, after which the 400 μL (1 mg) protein lysate was added, and the samples were rotated and incubated at 4 °C for 2 h. After centrifugation at 2000 rpm/min at 4 °C for 2 min, they were washed with PBS 3 times, then the precipitation was collected and added into 1 × Loading Buffer and boiled for 5 min. The supernatant was collected after centrifugation at 12,000 r/min at 4 °C for 5 min and then prepared for the Western Blot experiment (see Section 2.9).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!